The effect of soluble LAG-3 (CD223) treatment in fetal thymic organ culture. [electronic resource]
- Biotechnology letters Sep 2004
- 1371-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0141-5492
10.1023/B:BILE.0000045635.63873.96 doi
Animals Antigens, CD--pharmacology CD4-Positive T-Lymphocytes--physiology CD40 Antigens--metabolism Cell Differentiation--drug effects Epithelial Cells--physiology Fetus Histocompatibility Antigens Class II--metabolism Mice Mice, Inbred BALB C Mice, Transgenic Organ Culture Techniques Recombinant Proteins--pharmacology Thymus Gland Lymphocyte Activation Gene 3 Protein